New Zealand markets closed

CERo Therapeutics Holdings, Inc. (CERO)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
0.9900-0.0300 (-2.94%)
At close: 04:00PM EDT
0.9985 +0.01 (+0.86%)
After hours: 07:37PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
Cash flows from operating activities
Net income
-10,752
-11,829
-10,630
Depreciation & amortisation
1,095
1,073
735.473
Stock-based compensation
286.407
381.07
287.735
Change in working capital
4.314
-1,297
492.34
Accounts payable
77.953
-68.734
212.174
Other working capital
-9,636
-12,404
-10,707
Net cash provided by operating activities
-9,352
-11,709
-10,094
Cash flows from investing activities
Investments in property, plant and equipment
-
-694.232
-612.566
Net cash used for investing activities
-284.252
-694.232
-612.566
Cash flows from financing activities
Net cash used provided by (used for) financing activities
10.792
5.625
60.255
Net change in cash
-9,625
-12,398
-10,647
Cash at beginning of period
15,013
19,217
29,864
Cash at end of period
5,388
6,820
19,217
Free cash flow
Operating cash flow
-9,352
-11,709
-10,094
Capital expenditure
-
-694.232
-612.566
Free cash flow
-9,636
-12,404
-10,707